The document summarizes regulatory perspectives for entering global pharmaceutical markets. It discusses projections that the global pharmaceutical market will reach between $1.135 trillion and $1.235 trillion by 2017, with the United States holding the largest market share at 31% and emerging markets accounting for an increasing portion. It then provides an overview of drug regulations, noting they vary between regions but aim to protect public health. The regulatory approval processes and requirements in major markets like the US, Europe, Japan, and other regions are then outlined.